Clinuvel Pharmaceuticals | CUV - Gross Profit On Sales

Stock Price
9.20
Daily Change
0.07 0.77%
Monthly
0.44%
Yearly
-14.34%
Q2 Forecast
9.29

Clinuvel Pharmaceuticals reported AUD57.82M in Gross Profit on Sales for its fiscal semester ending in June of 2024.





Gross Profit On Sales Change Date
Avita Medical AUD 14.31M 639K Dec/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Mesoblast USD 3.16M 9.61M Dec/2024
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Pacific Edge NZD 5.2M 1.75M Jun/2024
Paradigm Biopharmaceuticals AUD -9K 423.94K Jun/2025
PYC Therapeutics AUD 5.83M 750K Jun/2025
Telix Pharmaceuticals AUD 217.82M 9.23M Dec/2025